早产儿早期氨基酸摄入与5岁时全量表智商的关系
该研究基于法国63个新生儿重症监护病房的EPIPAGE-2前瞻性人群队列,采用倾向评分匹配分析,比较出生胎龄小于30周的早产儿在7日龄时高氨基酸摄入(3.51-4.50 g/kg/d)与未高摄入者的5岁全量表智商(FSIQ)。主要结局为FSIQ大于-1 SD(即≥93分),暴露组发生率61.4%(243/396)高于非暴露组54.4%(206/379),OR 1.33(95%CI 1.00-1.71),每100名婴儿绝对风险增加7.01(95%CI 0.06-13.87),P=.048。匹配队列中,7日龄每1.00 g/kg/d氨基酸摄入与FSIQ评分相关(β=2.43,95%CI 0.27-4.59,P=.03),并与白质面积、胼胝体及各向异性等MRI指标相关。作者认为高氨基酸摄入与5岁FSIQ大于-1 SD的几率升高相关,需设计良好的随机研究长期随访证实。
要点
- 出生胎龄小于30周早产儿,7日龄氨基酸摄入3.51-4.50 g/kg/d者5岁时FSIQ≥93分的比例61.4%(243/396),未暴露者54.4%(206/379),OR 1.33(95%CI 1.00-1.71;P=.048)。
- 匹配队列中7日龄每1.00 g/kg/d氨基酸摄入与5岁FSIQ评分相关(n=775;β=2.43,95%CI 0.27-4.59;P=.03)。
- 工具变量法在总体队列978名参与者中调整OR为1.30(95%CI 1.16-1.46),多重插补在匹配队列1290名参与者中调整OR为1.35(95%CI 1.05-1.75)。
- 国际专家委员会近期建议,超过3.50 g/kg/d的氨基酸摄入仅应给予临床试验中的早产儿。
- 作者认为需设计良好的随机研究并长期随访,以证实该营养方法的获益。
适用人群与场景
- 出生胎龄小于30周的早产儿,来自法国63个新生儿重症监护病房的EPIPAGE-2前瞻性人群队列,2011年4月1日至12月31日招募。
- 暴露组为7日龄时氨基酸摄入3.51-4.50 g/kg/d者,非暴露组为未达到该摄入量者。
诊断标准与关键阈值
- 主要结局:5岁时全量表智商(FSIQ)评分大于-1 SD(即≥93分)。
- 暴露定义:7日龄时氨基酸摄入3.51-4.50 g/kg/d。
研究设计与关键结果
- 研究设计:EPIPAGE-2前瞻性人群队列,倾向评分匹配分析,2016年9月1日至2017年12月31日随访至5岁;共1789名早产儿(929名男孩,51.9%;平均胎龄27.17周,SD 1.50),暴露组938名,非暴露组851名,匹配后每组717名可配对。
- 主要结局:5岁时仍存活且已知结局的暴露组396名中243名(61.4%)FSIQ≥93分,非暴露组379名中206名(54.4%),OR 1.33(95%CI 1.00-1.71);每100名婴儿绝对风险增加7.01(95%CI 0.06-13.87);P=.048。
- 匹配队列中,7日龄每1.00 g/kg/d氨基酸摄入与5岁FSIQ评分相关(n=775;β=2.43,95%CI 0.27-4.59;P=.03)。
- MRI亚组:白质面积(n=134;β=144/mm²,95%CI 3-285/mm²;P=.045);胼胝体各向异性(n=50;β=0.018,95%CI 0.016-0.021;P<.001);左侧上纵束(n=42;β=0.018,95%CI 0.010-0.025;P<.001);右侧上纵束(n=42;β=0.014,95%CI 0.005-0.024;P=.003)。
- 确认性分析:工具变量法在总体队列978名参与者中调整OR 1.30(95%CI 1.16-1.46);多重插补在匹配队列1290名参与者中调整OR 1.35(95%CI 1.05-1.75)。
证据类型、等级与局限
- 证据类型:前瞻性人群队列研究(EPIPAGE-2),采用倾向评分匹配分析和工具变量法。
- 国际专家委员会近期修订建议,超过3.50 g/kg/d的氨基酸摄入仅应给予临床试验中的早产儿。
- 局限:原文未报告局限性;作者指出需设计良好的随机研究并长期随访以证实获益。
对床旁实践的改变
- 国际专家委员会建议,超过3.50 g/kg/d的氨基酸摄入仅应给予临床试验中的早产儿。
- 作者认为,7日龄高氨基酸摄入(3.51-4.50 g/kg/d)与5岁FSIQ大于-1 SD的几率升高相关,需设计良好的随机研究并长期随访证实该营养方法的获益。
指南或共识出处
- 国际专家委员会建议(原文引用,未注明机构名称)。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: An international expert committee recently revised its recommendations on amino acid intake for very preterm infants, suggesting that more than 3.50 g/kg/d should be administered only to preterm infants in clinical trials. However, the optimal amino acid intake during the first week after birth in these infants is unknown.
OBJECTIVE: To evaluate the association between early amino acid intake and cognitive outcomes at age 5 years.
DESIGN, SETTING, AND PARTICIPANTS: Using the EPIPAGE-2 (Epidemiologic Study on Small-for-Gestational-Age Children-Follow-up at Five and a Half Years) cohort, a nationwide prospective population-based cohort study conducted at 63 neonatal intensive care units in France, a propensity score-matched analysis was performed comparing infants born at less than 30 weeks' gestation who had high amino acid intake (3.51-4.50 g/kg/d) at 7 days after birth with infants who did not. Participants were recruited between April 1 and December 31, 2011, and followed up from September 1, 2016, to December 31, 2017. Full-scale IQ (FSIQ) was assessed at age 5 years. A confirmatory analysis used neonatal intensive care unit preference for high early amino acid intake as an instrumental variable to account for unmeasured confounding. Statistical analysis was performed from January 15 to May 15, 2021.
EXPOSURES: Amino acid intake at 7 days after birth.
MAIN OUTCOMES AND MEASURES: The primary outcome was an FSIQ score greater than -1 SD (ie, ≥93 points) at age 5 years. A complementary analysis was performed to explore the association between amino acid intake at day 7 as a continuous variable and FSIQ score at age 5 years. Data from cerebral magnetic resonance imaging at term were available for a subgroup of preterm infants who participated in the EPIRMEX (Cerebral Abnormalities Detected by MRI, Realized at the Age of Term and the Emergence of Executive Functions) ancillary study.
RESULTS: Among 1789 preterm infants (929 boys [51.9%]; mean [SD] gestational age, 27.17 [1.50] weeks) with data available to determine exposure to amino acid intake of 3.51 to 4.50 g/kg/d at 7 days after birth, 938 infants were exposed, and 851 infants were not; 717 infants from each group could be paired. The primary outcome was known in 396 of 646 exposed infants and 379 of 644 nonexposed infants who were alive at age 5 years and was observed more frequently among exposed vs nonexposed infants (243 infants [61.4%] vs 206 infants [54.4%], respectively; odds ratio [OR], 1.33 [95% CI, 1.00-1.71]; absolute risk increase in events [ie, the likelihood of having an FSIQ score >-1 SD at age 5 years] per 100 infants, 7.01 [95% CI, 0.06-13.87]; P = .048). In the matched cohort, correlation was found between amino acid intake per 1.00 g/kg/d at day 7 and FSIQ score at age 5 years (n = 775; β = 2.43 per 1-point increase in FSIQ; 95% CI, 0.27-4.59; P = .03), white matter area (n = 134; β = 144 per mm2; 95% CI, 3-285 per mm2; P = .045), anisotropy of the corpus callosum (n = 50; β = 0.018; 95% CI, 0.016-0.021; P < .001), left superior longitudinal fasciculus (n = 42; β = 0.018; 95% CI, 0.010-0.025; P < .001), and right superior longitudinal fasciculus (n = 42; β = 0.014 [95% CI, 0.005-0.024; P = .003) based on magnetic resonance imaging at term. Confirmatory and sensitivity analyses confirmed these results. For example, the adjusted OR for the association between the exposure and the primary outcome was 1.30 (95% CI, 1.16-1.46) using the instrumental variable approach among 978 participants in the overall cohort, and the adjusted OR was 1.35 (95% CI, 1.05-1.75) using multiple imputations among 1290 participants in the matched cohort.
CONCLUSIONS AND RELEVANCE: In this cohort study, high amino acid intake at 7 days after birth was associated with an increased likelihood of an FSIQ score greater than -1 SD at age 5 years. Well-designed randomized studies with long-term follow-up are needed to confirm the benefit of this nutritional approach.
参考来源
- Rozé JC, Morel B, Lapillonne A, et al. Association Between Early Amino Acid Intake and Full-Scale IQ at Age 5 Years Among Infants Born at Less Than 30 Weeks' Gestation. JAMA Netw Open. 2021. PMID: 34846527. doi:10.1001/jamanetworkopen.2021.35452
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。